Chemoinformaics analysis of Linalool oxide, pyrane, (Z)-
Molecular Weight | 170.252 | nRot | 1 |
Heavy Atom Molecular Weight | 152.108 | nRig | 7 |
Exact Molecular Weight | 170.131 | nRing | 1 |
Solubility: LogS | -1.027 | nHRing | 1 |
Solubility: LogP | 1.725 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 30.3063 |
nHD | 1 | BPOL | 19.7937 |
QED | 0.609 |
Synth | 4.124 |
Natural Product Likeliness | 2.677 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.007 |
CACO-2 | -4.237 |
MDCK | 0.0000265 |
BBB | 0.995 |
PPB | 0.67175 |
VDSS | 1.4 |
FU | 0.359627 |
CYP1A2-inh | 0.025 |
CYP1A2-sub | 0.462 |
CYP2c19-inh | 0.034 |
CYP2c19-sub | 0.885 |
CYP2c9-inh | 0.015 |
CYP2c9-sub | 0.557 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.629 |
CYP3a4-inh | 0.093 |
CYP3a4-sub | 0.3 |
CL | 9.54 |
T12 | 0.624 |
hERG | 0.014 |
Ames | 0.022 |
ROA | 0.223 |
SkinSen | 0.113 |
Carcinogencity | 0.216 |
EI | 0.451 |
Respiratory | 0.833 |
NR-Aromatase | 0.015 |
Antiviral | No |
Prediction | 0.945817 |